Henk Visscher
- Molecular Biology top 10%
- Oncology top 5%
- Surgery top 10%
- Cardiology and Cardiovascular Medicine top 5%
- Pediatrics, Perinatology and Child Health top 5%
- Co-authors
- Michael R. HaydenColin J.D. RossBruce CarletonLiam R. BrunhamShahrad R. RassekhRoshni R. SingarajaPaul RogersMichael Rieder
- Topics
- Acute Lymphoblastic Leukemia research (5 papers)Chemotherapy-induced cardiotoxicity and mitigation (5 papers)Childhood Cancer Survivors' Quality of Life (4 papers)
- Partner nations
- CanadaNetherlandsUnited States
In The Last Decade
Henk Visscher
21 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 88
- Molecular Biology 731
- Oncology 666
- Surgery 460
- Cardiology and Cardiovascular Medicine 412
- Pediatrics, Perinatology and Child Health 394
Countries citing papers authored by Henk Visscher
This map shows the geographic impact of Henk Visscher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henk Visscher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henk Visscher more than expected).
Fields of papers citing papers by Henk Visscher
This network shows the impact of papers produced by Henk Visscher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henk Visscher. The network helps show where Henk Visscher may publish in the future.
Co-authorship network of co-authors of Henk Visscher
This figure shows the co-authorship network connecting the top 25 collaborators of Henk Visscher. A scholar is included among the top collaborators of Henk Visscher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henk Visscher. Henk Visscher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 27 | |
| 3 | 7 | |
| 4 | 100 | |
| 5 | 89 | |
| 6 | 150 | |
| 7 | 148 | |
| 8 | 298 | |
| 9 | 120 | |
| 10 | 14 | |
| 11 | Pharmacogenomics of serious adverse drug reactions in pediatric oncology. | 24 |
| 12 | 61 | |
| 13 | 14 | |
| 14 | 22 | |
| 15 | 231 | |
| 16 | 171 | |
| 17 | 80 | |
| 18 | 19 | |
| 19 | 83 | |
| 20 | 202 |
About Henk Visscher
Henk Visscher is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Oncology, having authored 21 papers that have together received 1.9k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). The work is most often cited by research in Pharmacology (223 citations), Oncology (666 citations) and Pediatrics, Perinatology and Child Health (394 citations). Henk Visscher has collaborated with scholars based in Canada, Netherlands and United States. Frequent co-authors include Michael R. Hayden, Colin J.D. Ross, Bruce Carleton, Liam R. Brunham, Shahrad R. Rassekh, Roshni R. Singaraja, Paul Rogers, Michael Rieder, John J.P. Kastelein and Marie‐Pierre Dubé. Their work appears in journals such as Nature Genetics, Journal of Clinical Oncology and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.